Potential role of moxifloxacin in methicillin-resistant Staphylococcus aureus (MRSA) infections.
Butt
T
T
Ahmad
R N
RN
Usman
M
M
D001372:Aza Compounds / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy; D024841:Fluoroquinolones; D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D011804:Quinolines / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus
D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin